The Role of Curcumin in Modulating Inflammation and Oxidative Stress in Hypertensive Patients

Hypertension is a major health concern, with rising incidence rates and significant related morbidity and death. Hypertension's pathophysiology includes inflammation and oxidative stress, which both can lead to vascular dysfunction and cardiovascular problems. Curcumin, a bioactive compound found in turmeric, has sparked interest due to its significant anti-inflammatory and antioxidant properties, which might help manage hypertension. However, the specific impacts of curcumin on inflammation and oxidative stress in hypertensive patients are mostly unknown. This study is to fill this gap by undertaking a thorough review of available material. Using a quantitative technique, 380 hypertension patients (≥ 30 years of age) were randomly divided into two groups (experimental (190) and control (190)). Participants were randomized to receive either Curcumin (200 mg/day) plus standard therapy or Placebo plus standard therapy for a specified time (12 weeks). Blood pressure was tracked during the trial, and biomarkers of oxidative stress (MDA, GSH, SOD) and inflammation (CRP, IL-6, TNF alpha) were assessed both before and after the intervention. Compared to standard treatment, the experimental group receiving curcumin demonstrated highly significant improvements (p < 0.001) in all measured inflammatory markers (CRP, IL-6, TNF-alpha) and significant reductions in oxidative stress (MDA, p < 0.001) alongside increased antioxidant enzyme activity (SOD, p < 0.001). The mean reduction in systemic CRP was approximately 67% compared to baseline in the curcumin group (from 4.6 ±1.2 mg/L to 1.5 ±0.5 mg/L), significantly superior to the control group (p < 0.001). Furthermore, systolic blood pressure reduction was significantly enhanced in the curcumin group (p = 0.04). These results imply that curcumin may help individuals control their hypertension by reducing oxidative stress and inflammation.